Search results
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 3 days agoThat compares to 55.6% for Keytruda alone. Earlier in the year, one analyst called results from the...
7 Dividend Stocks to Buy Now: June 2024
InvestorPlace· 11 hours agoThese dividend stocks to buy now will reward investors with income now and growth as the market breadth expands.
12 recent scientific breakthroughs
The Week via Yahoo News· 5 days ago"And, if we do find signs of life elsewhere, we can tell if life on Earth and other planets derived from a common or different origin." 9. Inverse ...
Kenyan doctor spreads harmful disinformation about the WHO, vaccines and infertility
AFP via Yahoo News· 3 days agoKenyan doctor Wahome Ngare claimed several vaccines were “unnecessary” because they were designed to...
Washington conducted secret global anti-vaccine disinformation campaign against China
World Socialist Web Site· 7 days agoAn investigative report published by Reuters on June 14 revealed that the Pentagon conducted a...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 3 days agoIt will be important to watch how Pfizer stock performs as the company shores up its pipeline and...
Reasons to Hold West Pharmaceutical (WST) in Your Portfolio Now
Zacks via Yahoo Finance· 2 days agoDaVita’s shares have risen 35.7% compared with the industry’s 8.4% growth year to date. Boston...
25,274 Shares in Moderna, Inc. (NASDAQ:MRNA) Bought by Los Angeles Capital Management LLC
ETF DAILY NEWS· 2 days agoLos Angeles Capital Management LLC acquired a new position in shares of Moderna, Inc. (NASDAQ:MRNA – Free Report) during the 1st quarter, according to its most recent 13F filing with the Securities ...
Johnson & Johnson submits application to U.S. FDA seeking approval of TREMFYA® (guselkumab) for the...
Morningstar· 3 days agoFood and Drug Administration (FDA) seeking approval of TREMFYA® (guselkumab) for the treatment of adults with moderately to severely active Crohn's disease. The submission ...
Merck & Co., Inc. (NYSE:MRK) Shares Acquired by Buckingham Capital Management Inc.
ETF DAILY NEWS· 19 hours agoBuckingham Capital Management Inc. boosted its holdings in Merck & Co., Inc. (NYSE:MRK – Free Report) by 13.3% during the 1st quarter, HoldingsChannel reports. The institutional investor owned ...